Weekly Policy Update: Colorado BioScience Association’s Annual Day at the Capitol

This week CBSA held our annual Day at the Capitol event, bringing healthcare innovators to the state Capitol to highlight the discoveries and advancements taking place in Colorado to improve the health and lives of patients. Nearly 60 people attended the event to learn about the Association’s policy priorities for 2019 and how those priorities have led to CBSA’s engagement so far this session.

The event also included a discussion about the Association’s work to promote increased access to capital and highlighted efforts to foster the growth of the state-funded Advanced Industries Grant program. CBSA announced that since inception, the program has awarded more than 400 grants to Colorado bioscience companies, creating 79 new life science companies, 773 direct jobs, and $551.7 million in follow-on grants and investments.

Over the lunch hour, twelve companies showcased their innovations to state legislators and their staff, helping to tell the bioscience story and underscoring the impact of many of the priorities discussed during the day’s program. Thanks to the companies that participated in this year’s showcase:

o Center for Disease Control and Prevention (CDC)

o CereHealth


o Impressio

o Living Ink

o Medtronic

o MFB Fertility

o Osypka Medtec, Inc.

o Securisyn Medical

o Sharklet Technologies, Inc.

o STAQ Pharma

o Terumo BCT

o Zimmer Biomet

View the full photo album from Day at the Capitol here.

Categories: CBSA News